{"created":"2023-05-15T09:06:50.817867+00:00","id":13889,"links":{},"metadata":{"_buckets":{"deposit":"59ee2cad-04b5-4af2-a8b1-dd7c4c8230ec"},"_deposit":{"created_by":14,"id":"13889","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"13889"},"status":"published"},"_oai":{"id":"oai:sapmed.repo.nii.ac.jp:00013889","sets":["1658:1659:2036"]},"author_link":["22045","22046","22047","22048","22049","22050","22051","22052","22053","22054","22055"],"item_3_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017-12-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1-6","bibliographicPageEnd":"107","bibliographicPageStart":"106","bibliographicVolumeNumber":"86","bibliographic_titles":[{"bibliographic_title":"札幌医学雑誌 = The Sapporo Medical Journal"},{"bibliographic_title":"The Sapporo Medical Journal","bibliographic_titleLang":"en"}]}]},"item_3_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"慢性腎臓病による心筋梗塞の拡大には，心筋リンゴ酸アスパラギン酸シャトル抑制を介したAkt活性化障害が関与し，慢性的なエリスロポエチン受容体刺激はこれらの障害を修復して心筋梗塞の拡大を予防する。","subitem_description_type":"Abstract"}]},"item_3_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"札幌医科大学"}]},"item_3_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0036-472X","subitem_source_identifier_type":"ISSN"}]},"item_3_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Nishizawa, K"}],"nameIdentifiers":[{"nameIdentifier":"22045","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yano, T"}],"nameIdentifiers":[{"nameIdentifier":"22046","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Tanno, M"}],"nameIdentifiers":[{"nameIdentifier":"22047","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Miki, T"}],"nameIdentifiers":[{"nameIdentifier":"22048","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kuno, A"}],"nameIdentifiers":[{"nameIdentifier":"22049","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Tobisawa, T"}],"nameIdentifiers":[{"nameIdentifier":"22050","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ogasawara, M"}],"nameIdentifiers":[{"nameIdentifier":"22051","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Muratsubaki, S"}],"nameIdentifiers":[{"nameIdentifier":"22052","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ohno, K"}],"nameIdentifiers":[{"nameIdentifier":"22053","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ishikawa, S"}],"nameIdentifiers":[{"nameIdentifier":"22054","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Miura, T"}],"nameIdentifiers":[{"nameIdentifier":"22055","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-02-23"}],"displaytype":"detail","filename":"0036472X86106.pdf","filesize":[{"value":"819.5 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"0036472X86106","url":"https://sapmed.repo.nii.ac.jp/record/13889/files/0036472X86106.pdf"},"version_id":"1425e14a-3003-4ae8-b140-02b458abe1d9"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"Chronic treatment with an erythropoietin receptor ligand prevents chronic kidney disease–induced enlargement of myocardial infarct size","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Chronic treatment with an erythropoietin receptor ligand prevents chronic kidney disease–induced enlargement of myocardial infarct size","subitem_title_language":"en"}]},"item_type_id":"3","owner":"14","path":["2036"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2019-02-23"},"publish_date":"2019-02-23","publish_status":"0","recid":"13889","relation_version_is_last":true,"title":["Chronic treatment with an erythropoietin receptor ligand prevents chronic kidney disease–induced enlargement of myocardial infarct size"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2023-12-13T02:16:52.388301+00:00"}